US DoD Uniformed Services University Travelers’ Diarrhea Clinical Update
November 15, 2021 06:00 ET
|
Immuron Limited
Key Points Manufacture of investigational medical products to support the Uniformed Services University (USU) clinical program to evaluate the efficacy of Travelan® and two other non-antibiotic OTC...
US DoD Naval Medical Research Center Clinical Update
November 10, 2021 06:00 ET
|
Immuron Limited
Key Points Manufacture of investigational medical products to support the US Naval Medical Research Centre (NMRC) clinical programs completed.IND submission to the U.S. Food and Drug administration...
IMM-124E – Demonstrates Antiviral T-Cell Immunity
October 08, 2021 06:00 ET
|
Immuron Limited
Key Points International Patent Filed Publication from the Hebrew University - Hadassah Medical Center Entitled: Augmented antiviral T cell immunity by oral administration of IMM-124E in preclinical...
Immuron Director resignation
September 23, 2021 23:00 ET
|
Immuron Limited
MELBOURNE, Australia, Sept. 24, 2021 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral...
Immuron planned Acquisition of R&D Vaccine Company
September 23, 2021 09:00 ET
|
Immuron Limited
MELBOURNE, Australia, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral...
Innovation Metals Corp. Successfully Completes Initial Extraction-Rate Testing of the RapidSX™ Technology for Rare-Earth Elements Separation
July 06, 2021 09:50 ET
|
Innovation Metals Corp.
TORONTO, July 06, 2021 (GLOBE NEWSWIRE) -- Innovation Metals Corp. (“IMC” or the “Company”) is pleased to announce the successful completion of initial extraction-rate testing of its proprietary...
IMM124E – May offer a New modality for Inhibition of SARS-CoV-2
May 13, 2021 06:00 ET
|
Immuron Limited
Key Points Monash University Research Update on SARS-CoV-2 programBiomedicine Discovery Institute initiates program to isolate and identify the inhibitory molecule/s in IMM-124E Appointment of Chief...
Innovation Metals Corp. Announces Execution of RapidSX™ Separation Technology Testing Agreement with Rare-Earth Producer
May 04, 2021 10:04 ET
|
Innovation Metals Corp.
TORONTO, May 04, 2021 (GLOBE NEWSWIRE) -- Innovation Metals Corp. (“IMC” or the “Company”) is pleased to announce the execution of a binding Technology Testing Agreement (“TTA”) with a leading,...
Fluidigm Announces Conference Call and Webcast of First Quarter 2021 Financial Results
April 08, 2021 08:30 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Innovation Metals Corp. Provides Market Commentary on Recent Rare-Earth Industry Developments
February 22, 2021 11:06 ET
|
Innovation Metals Corp.
TORONTO, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Innovation Metals Corp. (“IMC” or the “Company”) is pleased to provide the following commentary on recent notable developments in the rare-earth elements...